Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients

References

• Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J clin oncol. 2013;31:4550–59. doi:10.1200/jco.2013.50.3870. PMID:24248688.
   PubMed Web of Science ®Google Scholar
• Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, Soerjomataram I. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67:51–64. doi:10.3322/caac.21384. PMID:28076666.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J clin oncol. 2008;26:612–19. doi:10.1200/jco.2007.14.1713. PMID:18235120.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J clin oncol. 2015;33:3235–42. doi:10.1200/jco.2015.61.6995. PMID:26351338.
   PubMed Web of Science ®Google Scholar
• Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus-associated cancers - United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018;67:918–24. doi:10.15585/mmwr.mm6733a2. PMID:30138307.
   PubMed Web of Science ®Google Scholar
• Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus-attributable cancers - United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019;68:724–28. doi:10.15585/mmwr.mm6833a3. PMID:31437140.
   PubMed Web of Science ®Google Scholar
• Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer. 2017;123:2219–29. doi:10.1002/cncr.30588. PMID:28346680.
   PubMed Web of Science ®Google Scholar
• Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, et al. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis. 2014;20:822–28. doi:10.3201/eid2005.131311. PMID:24751181.
   PubMed Web of Science ®Google Scholar
• Hirth JM, Chang M, Resto VA. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old). Vaccine. 2017;35:3446–51. doi:10.1016/j.vaccine.2017.05.025. PMID:28526331.
   PubMed Web of Science ®Google Scholar
• Pinto LA, Kemp TJ, Torres BN, Isaacs-Soriano K, Ingles D, Abrahamsen M, Pan Y, Lazcano-Ponce E, Salmeron J, Giuliano AR, et al. Quadrivalent Human Papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: results from the mid-adult male vaccine trial. J Infect Dis. 2016;214:1276–83. doi:10.1093/infdis/jiw359. PMID:27511896.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong ZY, Xiao W, Kahle L, Gillison ML. Effect of Prophylactic Human Papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2018;36:262–67. doi:10.1200/jco.2017.75.0141. PMID:29182497.
   PubMed Web of Science ®Google Scholar
• Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PloS One. 2013;8:e68329. doi:10.1371/journal.pone.0068329. PMID:23873171.
   PubMed Web of Science ®Google Scholar
• American Dental Association. Cancer prevention through HPV vaccination: an action guide for dental health care providers. Chicago (IL); 2018 [accessed 2020 Aug 27]. https://ebd.ada.org/~/media/ebd/files/dental-action-guide-web_ada.pdf?la=en.
   Google Scholar
• American Dental Association. Statement on human papillomavirus and squamous cell cancers of the oropharynx. Chicago (IL); 2012 [accessed 2020 Aug 25]. http://www.ada.org/1749.aspx.
   Google Scholar
• Walker KK, Jackson RD, Sommariva S, Neelamegam M, Desch J. USA dental health providers’ role in HPV vaccine communication and HPV-OPC protection: a systematic review. Hum Vaccine Immunother. 2019;15:1863–69. doi:10.1080/21645515.2018.1558690. PMID:30620632.
   PubMed Web of Science ®Google Scholar
• Stull CL, Lunos S. Knowledge, attitudes and practices regarding human papilloma virus communication and vaccine advocacy among minnesota dentists and dental hygienists. J Dent Hyg. 2019;93:33–42. PMID:30819844.
   PubMedGoogle Scholar
• Shukla A, Nyambose J, Vanucci R, Johnson LB, Welch K, Lind E, Villa A. Evaluating the effectiveness of human papillomavirus educational intervention among oral health professionals. J Cancer Educ. 2019;34:890–96. doi:10.1007/s13187-018-1391-z. PMID:30006799.
   PubMed Web of Science ®Google Scholar
• Zhao F, Qiao Y. Cervical cancer prevention in China: a key to cancer control. Lancet (London, England). 2019;393:969–70. doi:10.1016/s0140-6736(18)32849-6. PMID:30860036.
   PubMed Web of Science ®Google Scholar
• Liu J, Yang XL, Zhang SW, Zhu LP, Chen WQ. Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study. Cancer Commun (London, England). 2018;38:75. doi:10.1186/s40880-018-0345-5. PMID:30594248.
   PubMed Web of Science ®Google Scholar
• Zhang LW, Li J, Cong X, Hu XS, Li D, Wu LL, Hua H, Yu G-Y, Kerr AR. Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005-2013. Cancer Epidemiol. 2018;57:120–26. doi:10.1016/j.canep.2018.10.014. PMID:30396144.
   PubMed Web of Science ®Google Scholar
• Lam EW, Chan JY, Chan AB, Ng CS, Lo ST, Lam VS, Chan MMH, Ngai CM, Vlantis AC, Ma RKH, et al. Prevalence, clinicopathological characteristics, and outcome of human papillomavirus-associated oropharyngeal cancer in Southern Chinese patients. Cancer Epidemiol Biomarkers Prev. 2016;25:165–73. doi:10.1158/1055-9965.EPI-15-0869. PMID:26604268.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xia RH, Ye DX, Human Papillomavirus LJ. 16 infection and TP53 mutation: two distinct pathogeneses for oropharyngeal squamous cell carcinoma in an Eastern Chinese population. PloS One. 2016;11:e0164491. doi:10.1371/journal.pone.0164491. PMID:27749915.
   PubMed Web of Science ®Google Scholar
• Guo L, Yang F, Yin Y, Liu S, Li P, Zhang X, Chen D, Liu Y, Wang J, Wang K, et al. Prevalence of human papillomavirus type-16 in head and neck cancer among the Chinese population: a meta-analysis. Front Oncol. 2018;8:619. doi:10.3389/fonc.2018.00619. PMID:30619756.
   PubMed Web of Science ®Google Scholar
• Hu S, Xu X, Zhang Y, Liu Y, Yang C, Wang Y, Wang Y, Yu Y, Hong Y, Zhang X, et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: implications for vaccine roll-out in mainland China. Vaccine. 2021;39:35–44. doi:10.1016/j.vaccine.2020.11.029. PMID:33243631.
   PubMed Web of Science ®Google Scholar
• Sipp D, Frazer IH, Rasko JEJ. No Vacillation on HPV Vaccination. Cell. 2018;172:1163–67. doi:10.1016/j.cell.2018.02.045. PMID:29522737.
   PubMed Web of Science ®Google Scholar
• Liu DL, Xie YF, Shu R. Statistical analysis of current oral health care and dental education resources in China. Chin J Dent Res. 2019;22:37–43. doi:10.3290/j.cjdr.a41773. PMID:30746531.
   PubMed Web of Science ®Google Scholar
• Qin S, Fu JX, Chen MZ, Meng YT, Xu C, Luo Y. Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: a cross-sectional study. Vaccine. 2020;38:4732–39. doi:10.1016/j.vaccine.2020.05.017. PMID:32471777.
   PubMed Web of Science ®Google Scholar
• Chuang SL, Su WW, Chen SL, Yen AM, Wang CP, Fann JC, Chiu SYH, Lee Y-C, Chiu H-M, Chang D-C, et al. Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers. Cancer. 2017;123:1597–609. doi:10.1002/cncr.30517. PMID:28055109.
   PubMed Web of Science ®Google Scholar
• Rutkoski H, Tay DL, Dixon BL, Pinzon LM, Mooney R, Winkler JR, Kepka D. A multi-state evaluation of oral health students’ knowledge of human papillomavirus-related oropharyngeal cancer and HPV vaccination. Journal of Cancer Education : The Official Journal of the American Association for Cancer Education. 2020;35:1017–25. doi:10.1007/s13187-019-01561-y. PMID:31222578.
   PubMed Web of Science ®Google Scholar
• Lin Y, Lin Z, He F, Chen H, Lin X, Zimet GD, Alias H, He S, Hu Z, Wong LP, et al. HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: a study of adult women aged 27-45 years in China. Vaccine. 2020;38:3021–30. doi:10.1016/j.vaccine.2020.02.042. PMID:32127227.
   PubMed Web of Science ®Google Scholar
• Daley EM, Thompson EL, Vamos CA, Griner SB, Vazquez-Otero C, Best AL, Kline NS, Merrell LK. HPV-related knowledge among dentists and dental hygienists. J Cancer Educ. 2018;33:901–06. doi:10.1007/s13187-016-1156-5. PMID:28039675.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines. Ambulatory Pediatr. 2007;7:367–73. doi:10.1016/j.ambp.2007.05.010. PMID:17870645.
   PubMedGoogle Scholar
• Hosking YP, Cappelli D, Donly K, HPV RS. Vaccination and the role of the pediatric dentist: survey of graduate program directors. Pediatr Dent. 2017;39:383–89. PMID:29070161.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:89–99. doi:10.1016/S1470-2045(11)70286-8. PMID:22075171.
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928–43. doi:10.1056/NEJMoa061760. PMID:17494926.
   PubMed Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED, Jr.Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372:711–23. doi:10.1056/NEJMoa1405044. PMID:25693011.
   PubMed Web of Science ®Google Scholar
• Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, et al. Efficacy, safety, and immunogenicity of an escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J Natl Cancer Inst. 2020;112:145–53. doi:10.1093/jnci/djz074. PMID:31086947.
   PubMedGoogle Scholar
• Vázquez-Otero C, Vamos CA, Thompson EL, Merrell LK, Griner SB, Kline NS, Catalanotto FA, Giuliano AR, Daley EM. Assessing dentists’ human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc (1939). 2018;149:9–17. doi:10.1016/j.adaj.2017.08.021. PMID:29031503.
   PubMed Web of Science ®Google Scholar
• Daley E, Dodd V, DeBate R, Vamos C, Wheldon C, Kline N, Smith S, Chandler R, Dyer K, Helmy H, et al. Prevention of HPV-related oral cancer: assessing dentists’ readiness. Public Health. 2014;128:231–38. doi:10.1016/j.puhe.2013.12.002. PMID:24602857.
   PubMed Web of Science ®Google Scholar
• Wei F, Yin K, Wu X, Lan J, Huang S, Sheng W, Zhao J, Su Y, Wang Y, Li Y, et al. Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study. Emerging Microbes Infect. 2016;5:e119. doi:10.1038/emi.2016.118. PMID:27876782.
   PubMed Web of Science ®Google Scholar
• Fan S, Li P, Ouyang L, Yuan T, Gong H, Ding Y, Luo Z, Wu G, Yu M. Anal human papillomavirus infection among MSM attending university in China: implications for vaccination. Vaccines (Basel). 2020;8. doi:10.3390/vaccines8020175. PMID:32283842.
   Google Scholar
• Xu S, Sun B, Zhou R, Shi C, Han Y, Li J, Sun J, Tian Z, Zhang Z, Li J, et al. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129:236–45.e2. doi:10.1016/j.oooo.2019.11.008. PMID:31987673.
   PubMed Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–70. doi:10.1002/ijc.30716. PMID:28369882.
   PubMed Web of Science ®Google Scholar
• Hartwig S, St Guily JL, Dominiak-Felden G, Alemany L, de Sanjosé S. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe. Infect Agent Cancer. 2017;12:19. doi:10.1186/s13027-017-0129-6. PMID:28400857.
   PubMed Web of Science ®Google Scholar
• Buttmann-Schweiger N, Deleré Y, Klug SJ, Kraywinkel K. Cancer incidence in Germany attributable to human papillomavirus in 2013. BMC Cancer. 2017;17:682. doi:10.1186/s12885-017-3678-6. PMID:29037233.
   PubMed Web of Science ®Google Scholar
• Wang S, Han B, Wan Y, Liu J, Zhao T, Liu H, Cui F. Do male university students know enough about Human Papillomavirus (HPV) to make informed decisions about vaccination? Med Sci Monit. 2020;26:e924840. doi:10.12659/msm.924840. PMID:32603317.
   PubMed Web of Science ®Google Scholar